Veterinary Medicines

Cepemycin CTC 10 mg/g

Authorised
  • Chlortetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
Cepemycin CTC 10 mg/g
Active substance:
  • Chlortetracycline hydrochloride
Target species:
  • Cattle
  • Dog
  • Horse
  • Cat
Route of administration:
  • Ocular use

Product details

Active substance and strength:
  • Chlortetracycline hydrochloride
    10.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Eye ointment
Withdrawal period by route of administration:
  • Ocular use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Dog
    • Horse
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS01AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401766.00.00
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/01/2025
Download

2401766-parde-20160509.pdf

German (PDF)
Published on: 13/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."